Novo Nordisk has long offered to reimburse employees who are treated with its other drugs for conditions such as diabetes and hemophilia, though the perk has generated renewed attention as Wegovy has gained popularity. Employees are taxed on the benefit, and the drugmaker said it does not have a designated supply from which it pulls drugs for staff.
“Employees must of course meet with the general practitioner, be diagnosed and get a prescription, like any other Danish citizen,” the company said in an email to Bloomberg. “These pharmaceutical benefit practices also exist in other global organizations.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
